Evidence-based·Updated November 14, 2026·How we grade evidence

Rosuvastatin

MedicationStatin (prescription)

Rosuvastatin is a potent statin. In a 6-week label study, 5 to 40 mg lowered LDL cholesterol by 45 to 63 percent, and in two large trials it reduced heart attacks and strokes in people without known heart disease. Large trials found no reduction in heart events or deaths in chronic heart failure or in people on hemodialysis. Grapefruit-type interactions matter less than with simvastatin, but some prescription drugs, aluminum-magnesium antacids and red yeast rice do matter.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Adults with high LDL cholesterol or increased cardiovascular risk, and some children with familial high cholesterol, treated and monitored by a prescriber

Common dosing range

Set by your prescriber. The Crestor label gives 5 to 40 mg once daily for adults; Asian patients start at 5 mg, and severe kidney impairment starts at 5 mg with a 10 mg maximum

When to expect effects

LDL falls within weeks; the label says the maximum LDL reduction is usually reached by 4 weeks. Fewer heart events were seen within about 2 years in JUPITER

Watch out for

Muscle injury (myopathy, rarely rhabdomyolysis) is more likely at 40 mg, after age 65, with kidney impairment or untreated low thyroid, in Asian patients, and with drugs such as cyclosporine, gemfibrozil and some antivirals. Aluminum and magnesium hydroxide antacids taken at the same time halved rosuvastatin absorption. Statins lower blood CoQ10, but evidence that CoQ10 pills relieve muscle aches is mixed

What is it

Rosuvastatin is a prescription cholesterol-lowering medicine in the statin class, sold as Crestor and as generic rosuvastatin calcium tablets. It is used to lower LDL ("bad") cholesterol, to slow the buildup of plaque in arteries, and to reduce the risk of heart attack, stroke and related events in adults at increased cardiovascular risk. It is also approved for some children with inherited (familial) high cholesterol. Unlike simvastatin, lovastatin and atorvastatin, rosuvastatin is not broken down to a meaningful extent by the CYP3A4 enzyme that grapefruit blocks. Its blood level depends instead on liver transport proteins (OATP1B1 and BCRP) and, to a small degree, the CYP2C9 enzyme, and several prescription drugs can block these.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

Your prescriber recommends a statin because of high LDL cholesterol, diabetes, other cardiovascular risk factors or familial high cholesterol
You need a larger LDL reduction than lower-intensity statins usually give, as decided with your prescriber
You take medicines or eat foods that interfere with CYP3A4 statins, such as grapefruit, and your prescriber prefers a statin that does not depend on that enzyme

Probably skip if…

You have acute liver failure or decompensated cirrhosis, or a past allergic reaction to rosuvastatin: the label lists these as contraindications
You take sofosbuvir/velpatasvir/voxilaprevir, ledipasvir/sofosbuvir, gemfibrozil or tafamidis, which the label says to avoid with rosuvastatin; with cyclosporine and several other drugs the label caps the dose, so your prescriber will plan around them
You are pregnant, unless your doctor has weighed the ongoing need with you, or you are breastfeeding, which the label does not recommend during treatment
The only reason would be chronic heart failure or hemodialysis: large trials that started rosuvastatin in these groups found no reduction in heart events or deaths

Evidence at a glance

heart attack and stroke prevention in adults without heart disease

Strong Evidence
Effect
About 24 to 44 percent fewer major cardiovascular events; about 1 percentage point absolute reduction over 5.6 years in HOPE-3
Best fit
Older adults without known heart disease who have raised CRP or intermediate cardiovascular risk
Time
Differences emerged within about 2 years

LDL cholesterol

Strong Evidence
Effect
About 43 to 50 percent lower LDL in trials of 10 to 20 mg
Best fit
Adults with high LDL cholesterol
Time
Weeks

heart events and survival in chronic heart failure

Strong Evidence
Effect
No significant difference in major events or deaths
Best fit
Not applicable
Time
Assessed over about 3 to 4 years

heart events in people on hemodialysis

Good Evidence
Effect
No significant difference in major cardiovascular events or deaths
Best fit
Not applicable
Time
Assessed over 3.8 years

Evidence for 4 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

heart attack and stroke prevention in adults without heart disease

Disease adjunct
Strong Evidence

JUPITER randomized 17,802 healthy men 50 and older and women 60 and older with LDL below 130 mg/dL and a high-sensitivity CRP of 2 mg/L or more to rosuvastatin 20 mg or placebo. It was stopped early after a median 1.9 years: the combined rate of heart attack, stroke, revascularization, hospitalization for unstable angina or cardiovascular death was 0.77 versus 1.36 per 100 person-years (hazard ratio 0.56). Heart attacks (hazard ratio 0.46) and strokes (0.52) were both lower, and death from any cause was 20 percent lower. HOPE-3 then gave rosuvastatin 10 mg or placebo to 12,705 intermediate-risk adults in 21 countries for a median 5.6 years: cardiovascular death, heart attack or stroke occurred in 3.7 versus 4.8 percent (hazard ratio 0.76). Trials stopped early can overstate benefit, and the absolute difference in HOPE-3 was about 1 percentage point over 5.6 years. Physician-reported diabetes was more common on rosuvastatin in JUPITER, and muscle symptoms (5.8 versus 4.7 percent) and cataract surgery (3.8 versus 3.1 percent) in HOPE-3.

Effect size
About 24 to 44 percent fewer major cardiovascular events; about 1 percentage point absolute reduction over 5.6 years in HOPE-3
Time to effect
Differences emerged within about 2 years
Best fit
Older adults without known heart disease who have raised CRP or intermediate cardiovascular risk
Less likely
Young adults at low risk, where the absolute benefit is very small

Bottom line: Two large trials show rosuvastatin lowers heart attacks and strokes in people at increased risk who do not yet have heart disease.

LDL cholesterol

Biomarker support
Strong Evidence

In JUPITER, rosuvastatin 20 mg lowered LDL cholesterol by 50 percent (and high-sensitivity CRP by 37 percent). In HOPE-3, average LDL over 5.6 years was 26.5 percent lower with 10 mg than with placebo.. In AURORA, 10 mg lowered LDL by 43 percent at 3 months in people on hemodialysis, from a mean of 100 mg/dL. LDL is a blood marker: lowering it does not guarantee fewer heart events, as AURORA showed.

Effect size
About 43 to 50 percent lower LDL in trials of 10 to 20 mg
Time to effect
Weeks
Best fit
Adults with high LDL cholesterol
Less likely
People whose main problem is not LDL, such as those on dialysis, where LDL fell without fewer heart events

Bottom line: A large, reliable LDL reduction.

heart events and survival in chronic heart failure

No benefit found
Strong Evidence

CORONA gave rosuvastatin 10 mg or placebo to 5,011 people aged 60 or older with ischemic systolic heart failure (NYHA class II to IV) for a median 32.8 months. LDL fell 45 percent, but cardiovascular death, heart attack or stroke was not significantly reduced (hazard ratio 0.92, 95% CI 0.83 to 1.02), nor was death from any cause (0.95); there were fewer hospitalizations for cardiovascular causes (2,193 versus 2,564). GISSI-HF gave 10 mg or placebo to 4,574 Italian adults with chronic heart failure of any cause for a median 3.9 years: 29 versus 28 percent died (hazard ratio 1.00). Both trials found the drug safe in this group. These results apply to starting rosuvastatin for heart failure, not to people who have other reasons to take a statin.

Effect size
No significant difference in major events or deaths
Time to effect
Assessed over about 3 to 4 years
Best fit
Not applicable
Less likely
People with chronic heart failure and no other reason for a statin

Bottom line: Rosuvastatin did not lower deaths or heart events in chronic heart failure.

heart events in people on hemodialysis

No benefit found
Good Evidence

AURORA randomized 2,776 people aged 50 to 80 on maintenance hemodialysis to rosuvastatin 10 mg or placebo for a median 3.8 years. LDL fell 43 percent, but cardiovascular death, heart attack or stroke occurred at 9.2 versus 9.5 events per 100 patient-years (hazard ratio 0.96, 95% CI 0.84 to 1.11), and death from any cause did not differ (hazard ratio 0.96). This is one trial, and it tested starting a statin in people already on dialysis.

Effect size
No significant difference in major cardiovascular events or deaths
Time to effect
Assessed over 3.8 years
Best fit
Not applicable
Less likely
Adults starting rosuvastatin after they are already on maintenance hemodialysis

Bottom line: Starting rosuvastatin on hemodialysis lowered LDL but not heart events.

How it works

Rosuvastatin blocks HMG-CoA reductase, the liver enzyme that controls an early step in making cholesterol. With less cholesterol made inside liver cells, the liver puts out more LDL receptors and pulls more LDL cholesterol out of the blood. The label says the maximum LDL reduction is usually reached by 4 weeks. The same pathway also makes coenzyme Q10, which is why blood CoQ10 levels fall on statins. About 20 percent of a dose reaches the bloodstream, and only about 10 percent is changed by the body into metabolites; most leaves unchanged through the bile and feces, with a half-life of about 19 hours. Transport proteins carry rosuvastatin into liver cells, so drugs that block them (cyclosporine, gemfibrozil and several hepatitis C and HIV medicines) can raise its level several-fold. Levels are also about 2 times higher in Asian patients and about 3 times higher in severe kidney impairment, which is why the label starts these groups on a lower dose.

How to take it

1. Typical dose
Your prescriber sets the dose. The Crestor label gives 5 to 40 mg once daily for adults, chosen by LDL level and cardiovascular risk. For children with heterozygous familial high cholesterol, it gives 5 to 10 mg for ages 8 to under 10 and 5 to 20 mg from age 10; for the homozygous form, 20 mg from age 7. Asian patients start at 5 mg because blood levels run about 2 times higher. In severe kidney impairment without dialysis, the label starts at 5 mg and caps the dose at 10 mg. Drug interactions also cap the dose: 5 mg with cyclosporine, darolutamide, belumosudil or vadadustat; 10 mg with gemfibrozil (which the label says to avoid), several hepatitis C and HIV medicines, and capmatinib, enasidenib, momelotinib, regorafenib or teriflunomide; 20 mg with tafamidis (which the label also says to avoid), ticagrelor, febuxostat or fostamatinib.
2. Higher studied dose
40 mg is the label maximum. The label says myopathy risk is greater at 40 mg than at lower doses, and dipstick protein and microscopic blood in the urine were more frequent at 40 mg. In a 6-week label study, 40 mg lowered LDL by 63 percent versus 7 percent on placebo (groups of 13 to 18 people).
3. Timing
Once daily at any time of day; morning and evening doses gave the same blood levels. If a dose is missed, the label says not to take an extra dose and to resume with the next dose.
4. With food
With or without food; food did not change absorption. Swallow tablets whole. If you use an aluminum and magnesium hydroxide antacid, the label says to take rosuvastatin at least 2 hours before the antacid.
5. Split dosing
No; one dose a day
6. How long to try
Usually long term. The label suggests checking LDL as early as 4 weeks after starting and when clinically needed after that

What to track

LDL cholesterol at the times your prescriber sets
Unexplained muscle pain, tenderness or weakness, especially with fever or feeling unwell, and dark urine (report promptly)
Liver tests before starting and when your doctor thinks they are needed; yellow skin or eyes needs prompt care
Blood sugar or HbA1c if you have or are at risk of diabetes
INR if you take warfarin, especially when rosuvastatin is started, stopped or changed
Any new medicine, antacid or supplement, checked with your pharmacist

Bottom line: A prescriber sets the dose, with lower starting doses for Asian patients and severe kidney impairment. The main everyday points are antacid timing, interacting prescription drugs and not stacking red yeast rice on top.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Headache (5.5 percent in short placebo-controlled label trials, versus 5.0 percent on placebo)Nausea (3.4 versus 3.1 percent)Muscle aches (2.8 versus 1.3 percent)Weakness or tiredness (2.7 versus 2.6 percent)Constipation (2.4 percent)

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the label says rosuvastatin may cause fetal harm based on how it works, and tells prescribers to stop it when pregnancy is recognized or to weigh the patient's ongoing needs; cholesterol treatment is generally not needed during pregnancy. Decades of observational data on statins have not shown a higher rate of major birth defects, but data on miscarriage are insufficient. Breastfeeding: limited case reports show rosuvastatin passes into breast milk, and the label says breastfeeding is not recommended during treatment. If you are pregnant, planning a pregnancy or breastfeeding, talk to your doctor.

Interactions

Niacin at cholesterol-lowering doses (1 gram a day or more)High

The Crestor label reports myopathy and rhabdomyolysis when niacin at 1 gram a day or more is combined with rosuvastatin, and asks prescribers to weigh the benefit and watch for muscle symptoms; it also says Asian patients may be at higher risk of myopathy on rosuvastatin. The rate has been measured only with another statin: in HPS2-THRIVE, adding extended-release niacin (with laropiprant) to simvastatin raised definite myopathy about 4-fold and did not significantly reduce major vascular events (13.2 versus 13.7 percent). Do not add high-dose niacin without your prescriber; the small amounts in a multivitamin are a different matter.

Cyclosporine, gemfibrozil and some hepatitis C or HIV medicinesHigh

These drugs block the transporters that carry rosuvastatin into the liver. In label studies, cyclosporine raised rosuvastatin exposure about 7-fold and sofosbuvir/velpatasvir/voxilaprevir about 7.4-fold, raising the risk of muscle breakdown. The label says to avoid sofosbuvir/velpatasvir/voxilaprevir, ledipasvir/sofosbuvir, gemfibrozil and tafamidis, caps rosuvastatin at 5 mg with cyclosporine, and at 10 mg with several other antivirals. Make sure every prescriber knows you take rosuvastatin.

Red yeast riceModerate

Red yeast rice contains monacolin K, which is the same molecule as the statin lovastatin, so taking it with rosuvastatin stacks two statins. Testing of 12 products found 0.10 to 10.09 mg of monacolin K per capsule, and 4 had raised levels of citrinin, a toxin that harms the kidneys in animals. The Crestor label lists other lipid-lowering therapies among the risk factors for muscle injury. In a 28-day trial in 190 adults, rosuvastatin 5 mg lowered LDL 35 percent more than placebo, while red yeast rice did not lower it significantly. Review it with your doctor or pharmacist before combining.

Pomegranate and pomegranate juiceModerate

Rosuvastatin does not depend on CYP3A4, and in 12 healthy men even 900 mL of pomegranate juice a day did not significantly change levels of simvastatin, a CYP3A4 statin. The concern for rosuvastatin rests on one case report: a 48-year-old man with possible underlying muscle disease, stable on rosuvastatin 5 mg every other day plus ezetimibe, developed rhabdomyolysis 3 weeks after starting pomegranate juice twice a week. Concentrated pomegranate extracts have not been tested. Mention regular pomegranate use to your pharmacist and report unexplained muscle pain or dark urine.

AlcoholModerate

The Crestor label says people who drink substantial amounts of alcohol or have a history of liver disease may be at higher risk of liver injury, and that chronic alcohol-related liver disease modestly raises rosuvastatin levels. Light drinking is not addressed. Discuss your drinking with your doctor, and report yellow skin or eyes or dark urine.

Aluminum and magnesium hydroxide antacidsModerate

Taken at the same time, a combination aluminum and magnesium hydroxide antacid cut rosuvastatin absorption by about half; taken 2 hours apart, the drop was about 20 percent. The label says to take rosuvastatin at least 2 hours before the antacid. Ask your pharmacist about other magnesium or aluminum products you use.

WarfarinModerate

The label says rosuvastatin significantly raised the INR in people taking warfarin. It tells prescribers to check the INR before starting rosuvastatin and often enough after starting, changing or stopping it until the INR is stable.

Coenzyme Q10 (CoQ10)Low

Statins lower blood CoQ10 because they block the pathway that makes it; in a meta-analysis of placebo-controlled trials, rosuvastatin lowered plasma CoQ10 by about 0.49 micromol/L, similar to other statins. In the CORONA heart failure trial, rosuvastatin lowered CoQ10, but people with low CoQ10 did not do worse on it. Whether CoQ10 pills ease statin muscle aches is unsettled: one meta-analysis of 12 trials found less muscle pain, another of 7 trials found no benefit. This is not a harmful combination; if you have muscle symptoms, talk to your prescriber before adding anything.

BerberineLow

In human liver cells grown in a lab, berberine increased the OATP1B1 transporter and the uptake of rosuvastatin into the cells. No human or animal study has shown that this changes rosuvastatin blood levels, cholesterol response or side effects. Tell your doctor or pharmacist before adding berberine, and report new muscle pain or weakness.

Oat fiber and oat branLow

Soluble oat fiber may bind statins in the gut. The evidence comes from mice fed atorvastatin with oat bran, where the cholesterol-lowering effect of a low statin dose was halved; it has not been tested with rosuvastatin in people. Ask your pharmacist whether to space a large oat-fiber supplement apart from your dose.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

Warnings (4)

+ niacin

high

Niacin taken at cholesterol-lowering amounts (1 gram a day or more) adds to rosuvastatin's risk of muscle injury, including rhabdomyolysis, a rare but severe breakdown of muscle that can harm the kidneys. The Crestor label reports cases of myopathy and rhabdomyolysis with lipid-modifying doses of niacin and asks prescribers to weigh the benefit against that risk and to monitor for muscle symptoms; it does not give a rate. The rate was measured with simvastatin, another statin: in a trial of 25,673 adults, adding extended-release niacin raised definite myopathy about 4-fold and did not reduce major vascular events. The small amounts of niacin in a multivitamin are not what the label describes.

+ red yeast rice

moderate

Red yeast rice contains monacolin K, a compound chemically identical to a statin, so taking it alongside rosuvastatin stacks a second statin-like HMG-CoA reductase inhibitor on top of the prescription statin. Because rosuvastatin is not broken down by the CYP3A4 enzyme, there is no enzyme-based (pharmacokinetic) interaction; the concern is purely additive statin-class exposure. This modestly raises the combined potential for statin-type muscle injury (myopathy, and rarely rhabdomyolysis) and liver injury beyond either agent alone. The added statin burden is usually small because red yeast rice's monacolin content is typically low, highly variable, and not shown on the label, but unregulated high-monacolin products can carry a more meaningful statin-like load.

+ berberine

low

Rosuvastatin is carried into liver cells by the OATP1B1 transporter. In a laboratory study using human liver-cell cultures, berberine increased OATP1B1 activity and pushed more rosuvastatin into the cells. This is an early, test-tube signal only: there is no human or animal data showing it changes blood levels, cholesterol response, or side-effect risk in real life.

+ coq10

low

Rosuvastatin blocks HMG-CoA reductase, the enzyme that makes both cholesterol and coenzyme Q10, so it modestly lowers circulating CoQ10. A meta-analysis of placebo-controlled trials found the drop was similar for rosuvastatin and for fat-soluble statins. Mitochondrial impairment is only one proposed mechanism for statin-associated muscle symptoms. This is a possible-benefit pairing, not a dangerous one.

See all 4 Rosuvastatin interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

An FDA-approved rosuvastatin product (Crestor or generic rosuvastatin calcium tablets) dispensed on your own prescription
The strength in mg per tablet (5, 10, 20 or 40 mg) and the instruction to take it once daily
A pharmacy leaflet or label note about spacing aluminum and magnesium antacids and about checking new medicines for interactions

Be skeptical of…

Red yeast rice or "natural statin" supplements presented as safe to take with rosuvastatin or as a replacement for it: they contain a statin in unstandardized amounts, and in one trial red yeast rice did not lower LDL significantly
Bergamot, berberine or other "cholesterol support" supplements added without telling your prescriber
Claims that CoQ10 will prevent or cure statin muscle pain: trial results are mixed
The idea that rosuvastatin has no interactions because grapefruit matters little: several prescription drugs and antacids do interact with it

Frequently asked questions

Can I take red yeast rice with rosuvastatin?⌄

Not without your prescriber's agreement. Red yeast rice contains monacolin K, the same compound as the prescription statin lovastatin, in amounts that varied 100-fold between products in one analysis, so taking both means taking two statins. In a 28-day trial, rosuvastatin 5 mg lowered LDL by about a third more than placebo, while red yeast rice did not lower it significantly.

Should I take CoQ10 with rosuvastatin?⌄

Rosuvastatin does lower CoQ10 in the blood, by about the same amount as other statins. Whether CoQ10 supplements help statin muscle aches is unclear, because meta-analyses disagree. The combination is not harmful, but if you have muscle symptoms, ask your doctor to look for causes and discuss the options; do not stop rosuvastatin on your own.

Are bergamot or berberine safe with rosuvastatin?⌄

There is no strong evidence of harm, and the grapefruit-type mechanism of bergamot matters little because rosuvastatin does not depend on CYP3A4. Berberine changed a rosuvastatin transporter in lab-grown liver cells, but no human study shows an effect on blood levels. Both are sold to lower cholesterol, so tell your prescriber or pharmacist if you use them, since they can change your LDL results.

Do antacids affect rosuvastatin?⌄

Yes, antacids containing aluminum and magnesium hydroxide can. Taken at the same time, one cut rosuvastatin absorption by about half. The label says to take rosuvastatin at least 2 hours before the antacid. Your pharmacist can tell you whether other stomach or magnesium products you use need spacing too.

Why do some people start rosuvastatin at a lower dose?⌄

Blood levels of rosuvastatin are about 2 times higher in Asian patients and about 3 times higher in severe kidney impairment, so the label starts both groups at 5 mg. Several medicines, such as cyclosporine and some antivirals, also raise levels and come with dose caps. Higher levels raise the risk of muscle injury, which is why your prescriber matches the dose to you.

What muscle symptoms should I report on rosuvastatin?⌄

Unexplained muscle pain, tenderness or weakness, especially with fever or feeling generally unwell, and dark or cola-colored urine. These can be signs of myopathy or rhabdomyolysis, which are rare but more likely at 40 mg, with interacting drugs, after age 65, and with kidney or untreated thyroid problems. Contact your prescriber promptly.

References by claim

heart attack and stroke prevention in adults without heart disease

Ridker et al., 2008 · PubMed (2008) link

Yusuf et al., 2016 · PubMed (2016) link

LDL cholesterol

Fellström et al., 2009 · PubMed (2009) link

heart events and survival in chronic heart failure

Kjekshus et al., 2007 · PubMed (2007) link

Tavazzi et al., 2008 · PubMed (2008) link

Safety

Crestor (rosuvastatin) tablets prescribing information · DailyMed (FDA label) link

Interaction: Red yeast rice

Gordon et al., 2010 · PubMed (2010) link

Laffin et al., 2023 · PubMed (2023) link

Interaction: Pomegranate and pomegranate juice

Sorokin et al., 2006 · PubMed (2006) link

Park et al., 2016 · PubMed (2016) link

Interaction: Coenzyme Q10 (CoQ10)

Banach et al., 2015 · PubMed (2015) link

McMurray et al., 2010 · PubMed (2010) link

Qu et al., 2018 · PMC (2018) link

Kennedy et al., 2020 · PubMed (2020) link

Interaction: Niacin at cholesterol-lowering doses (1 gram a day or more)

HPS2-THRIVE Collaborative Group et al., 2013 · PMC (2013) link

Landray et al., 2014 · PubMed (2014) link

Interaction: Berberine

Liu et al., 2020 · PMC (2020) link

Interaction: Oat fiber and oat bran

Eussen et al., 2011 · PubMed (2011) link

Track Rosuvastatin with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 14, 2026·Evidence current as of Nov 14, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.